<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 11.4: Contraindications: Liver, Kidney, and Cardiac Impairment</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - RED/ORANGE theme for Safety/Toxicology */
        .module-header {
            background: linear-gradient(135deg, #991b1b 0%, #dc2626 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #991b1b;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #dc2626;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #991b1b;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #fef2f2;
            border: 2px solid #ef4444;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #991b1b;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #991b1b;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #ef4444;
        }

        .term-item .term {
            font-weight: 700;
            color: #991b1b;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #991b1b;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #4b5563;
            margin: 30px 0 15px 0;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #fed7d7 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Welcome/Intro Box */
        .welcome-box {
            background: linear-gradient(135deg, #fef2f2 0%, #fee2e2 100%);
            padding: 30px 35px;
            border-radius: 14px;
            margin-bottom: 40px;
            border: 1px solid #fecaca;
        }

        .welcome-box h3 {
            margin: 0 0 15px 0;
            font-size: 20px;
            color: #991b1b;
            font-weight: 600;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #991b1b 0%, #dc2626 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #ef4444, #991b1b);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #991b1b 0%, #dc2626 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
            z-index: 1;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Tables */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        .data-table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        .data-table th {
            background: #f9fafb;
            padding: 15px;
            font-weight: 600;
            border-bottom: 2px solid #e5e7eb;
            color: #991b1b;
        }

        .data-table td {
            padding: 15px;
            border-bottom: 1px solid #f3f4f6;
            vertical-align: top;
        }

        /* Alert Boxes */
        .alert-box {
            padding: 26px 30px;
            margin: 35px 0;
            border-radius: 0 14px 14px 0;
            border-left: 5px solid;
        }

        .alert-box.warning {
            background: #fff8e6;
            border-left-color: #ff9800;
        }

        .alert-box.warning .alert-label {
            color: #e65100;
            font-weight: 600;
            text-transform: uppercase;
            font-size: 12px;
            letter-spacing: 1px;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
            position: relative;
        }

        .reveal-btn {
            background: #991b1b;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            font-size: 14px;
            cursor: pointer;
        }

        .answer-text {
            display: none;
            font-size: 14px;
            color: #991b1b;
            margin: 14px 0 0 0;
            padding: 14px;
            background: #fef2f2;
            border-radius: 8px;
        }

        .answer-text.show {
            display: block;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f3f4f6;
            padding: 25px;
            border-radius: 12px;
            margin-top: 40px;
        }

        .references-box {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .lesson-footer {
            text-align: center;
            padding-top: 50px;
            margin-top: 60px;
            border-top: 1px solid #eee;
        }

        @media (max-width: 768px) {
            .toc-list {
                grid-template-columns: 1fr;
            }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 11: Clinical Safety & Toxicology</p>
            <h1 class="lesson-title">Lesson 11.4: Contraindications: Liver, Kidney, and Cardiac Impairment</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 4 of 6</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Triad of Organ Safety</a></li>
                <li><a href="#section2"><span class="section-num">2</span>Hepatic Impairment & Hepatotoxicity</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Renal Function & Nephrotoxicity</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Cardiac Contraindications</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Botanical Red Flags Table</a></li>
                <li><a href="#section6"><span class="section-num">6</span>The V.I.T.A.L. Method Application</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Identify botanicals that are strictly contraindicated in pre-existing liver, kidney, or heart disease.</li>
                <li>Explain the mechanisms of <span class="highlight">idiosyncratic vs. intrinsic hepatotoxicity</span> in herbal medicine.</li>
                <li>Recognize how reduced Glomerular Filtration Rate (GFR) alters the safety profile of common herbs.</li>
                <li>Assess cardiac risk factors, including arrhythmias and hypertension, when formulating herbal protocols.</li>
                <li>Apply the "T" (Toxicological Screening) of the V.I.T.A.L. Method to high-risk clinical cases.</li>
            </ul>
        </div>

        <div class="welcome-box">
            <h3>Clinical Safety: Beyond the Basics</h3>
            <p>In clinical herbalism, the principle of <i>Primum non nocere</i> (First, do no harm) is most critical when working with clients who have compromised organ function. The liver and kidneys are the primary sites for <span class="highlight">metabolic clearance and excretion</span>, while the cardiovascular system is the delivery vehicle for all active constituents. When these systems are impaired, even "gentle" herbs can become toxic. This lesson provides the advanced toxicological framework required for safe professional practice.</p>
        </div>

        <h2 id="section1">1. The Triad of Organ Safety</h2>
        <p>The safety profile of any botanical is not static; it is a dynamic interaction between the herb's phytochemistry and the client's physiological capacity. We must view safety through the lens of the "Triad of Organ Safety"‚Äîthe Liver, Kidneys, and Heart. These three organs determine how a substance is processed, how long it remains in the body, and how it affects systemic pressure and rhythm.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">20%</div>
                    <div class="stat-label">HILI Cases in US/Europe</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">60+</div>
                    <div class="stat-label">GFR Safety Threshold</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">15%</div>
                    <div class="stat-label">Herbal Cardiac Events</div>
                </div>
            </div>
        </div>

        <p>A 2021 systematic review published in <i>The Lancet Gastroenterology & Hepatology</i> noted that <span class="highlight">Herb-Induced Liver Injury (HILI)</span> accounts for approximately 20% of drug-induced liver injury cases in the United States. This highlights the urgent need for practitioners to screen for pre-existing conditions before recommending high-potency extracts or long-term protocols.</p>

        <h2 id="section2">2. Hepatic Impairment & Hepatotoxicity</h2>
        <p>The liver is the "chemical factory" of the body, responsible for Phase I and Phase II detoxification. In clients with cirrhosis, hepatitis, or fatty liver disease, the enzymatic capacity (CYP450) is significantly reduced. This leads to the accumulation of active constituents to toxic levels.</p>

        <h3>Intrinsic vs. Idiosyncratic Hepatotoxicity</h3>
        <p>It is vital to distinguish between these two mechanisms:</p>
        <ul>
            <li><strong>Intrinsic Toxicity:</strong> Predictable and dose-dependent. For example, <span class="highlight">Pyrrolizidine Alkaloids (PAs)</span> found in Comfrey (<i>Symphytum officinale</i>) cause veno-occlusive disease at known cumulative doses.</li>
            <li><strong>Idiosyncratic Toxicity:</strong> Unpredictable and not necessarily dose-dependent. This is often an immune-mediated or genetic reaction. Kava (<i>Piper methysticum</i>) is the most famous example, where rare reactions occur despite standard dosing.</li>
        </ul>

        <div class="alert-box warning">
            <p class="alert-label">‚ö†Ô∏è Practitioner Warning: PAs</p>
            <p>Pyrrolizidine Alkaloids are unsaturated compounds that are converted into reactive pyrroles in the liver. These pyrroles bind to DNA and proteins, causing irreversible damage. <strong>Never</strong> administer PA-containing herbs (Comfrey, Coltsfoot, Borage leaf) internally to clients with any history of liver impairment.</p>
        </div>

        <h2 id="section3">3. Renal Function & Nephrotoxicity</h2>
        <p>The kidneys filter approximately 180 liters of blood daily. When renal function is impaired (Chronic Kidney Disease Stages 3-5), the body cannot effectively excrete water-soluble metabolites. This is particularly dangerous with herbs that have a narrow therapeutic window or those that affect electrolyte balance.</p>

        <h3>Key Concerns in Renal Impairment:</h3>
        <ol>
            <li><strong>Electrolyte Shifts:</strong> Herbs like Licorice (<i>Glycyrrhiza glabra</i>) can cause potassium depletion (hypokalemia), which is life-threatening in kidney patients.</li>
            <li><strong>Heavy Metal Accumulation:</strong> Compromised kidneys are less able to excrete trace heavy metals sometimes found in low-quality herbal products.</li>
            <li><strong>Oxalate Load:</strong> High-oxalate herbs (e.g., Sorrel, Rhubarb) can exacerbate calcium-oxalate stone formation in susceptible individuals.</li>
        </ol>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üìã</div>
                <div>
                    <p class="box-label">Case Study: The Licorice Complication</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">üë®</div>
                    <div class="patient-info">
                        <h4>Robert, 62</h4>
                        <p>History of Stage 3 CKD and Hypertension</p>
                    </div>
                </div>
                <p><strong>Presentation:</strong> Robert sought herbal support for "adrenal fatigue" and gastric ulcers. He began taking a high-dose Licorice solid extract (non-deglycyrrhizinated) recommended by a local health food store.</p>
                <p><strong>Outcome:</strong> Within 3 weeks, Robert presented to the ER with severe edema, a blood pressure of 190/110 mmHg, and profound muscle weakness. Lab work showed serum potassium at 2.8 mEq/L (Critical hypokalemia).</p>
                <p><strong>Practitioner Insight:</strong> Licorice inhibits the enzyme 11Œ≤-HSD2, leading to "apparent mineralocorticoid excess." In a client with CKD, the kidneys cannot compensate for this hormonal shift, leading to sodium retention and potassium loss.</p>
            </div>
        </div>

        <h2 id="section4">4. Cardiac Contraindications</h2>
        <p>Botanicals can interact with the heart through various mechanisms: altering ion channels (arrhythmias), changing the force of contraction (inotropy), or affecting the speed of the heart rate (chronotropy).</p>

        <p>Clients with <span class="highlight">Atrial Fibrillation (AFib)</span>, congestive heart failure, or a history of myocardial infarction require extreme caution. For instance, herbs containing cardiac glycosides (e.g., Lily of the Valley, Foxglove) are strictly avoided in professional clinical herbalism due to their extremely narrow therapeutic index and risk of cardiac arrest.</p>

        <h2 id="section5">5. Botanical Red Flags Table</h2>
        <p>The following table summarizes high-risk botanicals and the specific organ impairment that contraindicates their use.</p>

        <div class="data-table-container">
            <table class="data-table">
                <thead>
                    <tr>
                        <th>Botanical (Latin Name)</th>
                        <th>Primary Concern</th>
                        <th>Contraindicated Condition</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><i>Symphytum officinale</i> (Comfrey)</td>
                        <td>Pyrrolizidine Alkaloids</td>
                        <td>Cirrhosis, Hepatitis, Liver Failure</td>
                    </tr>
                    <tr>
                        <td><i>Glycyrrhiza glabra</i> (Licorice)</td>
                        <td>Pseudo-aldosteronism</td>
                        <td>Hypertension, CKD, Heart Failure</td>
                    </tr>
                    <tr>
                        <td><i>Piper methysticum</i> (Kava)</td>
                        <td>Idiosyncratic Hepatotoxicity</td>
                        <td>Active Liver Disease, Alcoholism</td>
                    </tr>
                    <tr>
                        <td><i>Ephedra sinica</i> (Ma Huang)</td>
                        <td>Sympathomimetic Stimulant</td>
                        <td>Arrhythmia, Coronary Artery Disease</td>
                    </tr>
                    <tr>
                        <td><i>Arctostaphylos uva-ursi</i></td>
                        <td>Hydroquinone toxicity</td>
                        <td>Severe Renal Impairment (Long-term)</td>
                    </tr>
                    <tr>
                        <td><i>Digitalis purpurea</i> (Foxglove)</td>
                        <td>Cardiac Glycosides</td>
                        <td>All Cardiac Conditions (Toxic)</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section6">6. The V.I.T.A.L. Method Application</h2>
        <p>Under the <strong>V.I.T.A.L. Method‚Ñ¢</strong>, organ safety falls squarely under the "T"‚ÄîToxicological & Safety Screening. However, it also informs the "I" (Individualized Formulation).</p>

        <div class="principle-card">
            <div class="principle-title">V.I.T.A.L. Step 'T': The Safety Screen</div>
            <p class="principle-text">Before any formula is drafted, the practitioner must:</p>
            <ul>
                <li>Request recent lab work (CMP - Comprehensive Metabolic Panel) to check AST/ALT (Liver) and eGFR/Creatinine (Kidney).</li>
                <li>Cross-reference all herbs against the client's specific organ pathology.</li>
                <li>Adjust dosage based on clearance rates; for example, if GFR is 45 (moderate impairment), consider reducing dosage by 25-50% for systemic herbs.</li>
            </ul>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <div class="question-number">1</div>
                <p class="question-text">Why is idiosyncratic hepatotoxicity (like that seen with Kava) more difficult to manage clinically than intrinsic toxicity (like PAs)?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Idiosyncratic toxicity is unpredictable, not dose-dependent, and often occurs in individuals without pre-existing risk factors, making it impossible to prevent simply by following "standard" doses. Intrinsic toxicity, conversely, is predictable and can be avoided by staying below known cumulative safety thresholds.</div>
            </div>

            <div class="question-item">
                <div class="question-number">2</div>
                <p class="question-text">A client with an eGFR of 35 wants to take a high-oxalate herbal blend for kidney stones. What is the clinical risk?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">With a reduced GFR (Stage 3b CKD), the kidneys cannot effectively filter and excrete high loads of oxalates. This increases the risk of further calcium-oxalate crystal deposition within the renal tubules, potentially accelerating the decline in kidney function.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Organ Clearance:</strong> The liver and kidneys determine the "half-life" of herbal constituents; impairment leads to accumulation and toxicity.</li>
                <li><strong>Liver Safety:</strong> Avoid all PA-containing herbs internally for liver patients; monitor for idiosyncratic reactions with Kava and Black Cohosh.</li>
                <li><strong>Renal Safety:</strong> Licorice is the most significant "red flag" herb for kidney patients due to its effect on potassium and blood pressure.</li>
                <li><strong>Cardiac Safety:</strong> Avoid stimulants (Ephedra, high-dose Caffeine) and cardiac glycosides in any patient with a history of arrhythmia or heart failure.</li>
                <li><strong>Evidence-Based Practice:</strong> Always request current lab markers (eGFR, ALT/AST) before working with high-risk clinical populations.</li>
            </ul>
        </div>

        <div class="references-box">
            <p><strong>References & Further Reading:</strong></p>
            <ul>
                <li>Hoofnagle, J. H., et al. (2021). "Liver Injury from Herba and Dietary Supplements." <i>The Lancet Gastroenterology & Hepatology</i>.</li>
                <li>Garc√≠a-Cort√©s, M., et al. (2016). "Hepatotoxicity by Dietary Supplements: A Tabular Listing and Clinical Characteristics." <i>International Journal of Molecular Sciences</i>.</li>
                <li>National Institutes of Health (2023). "LiverTox: Clinical and Research Information on Drug-Induced Liver Injury." <i>NCBI Bookshelf</i>.</li>
                <li>Wojcikowski, K., et al. (2004). "Herbal medicines and the kidney: safe or toxic?" <i>Journal of Nephrology</i>.</li>
                <li>Teschke, R., et al. (2015). "Kava hepatotoxicity: Clinical determinants and aromatic pathobiochemistry." <i>Phytomedicine</i>.</li>
                <li>Brinker, F. (2010). "Herb Contraindications and Drug Interactions." <i>Eclectic Medical Publications</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy Certified Herbalism Practitioner</p>
            <p class="copyright">&copy; 2024 AccrediPro Academy. All rights reserved. Professional Use Only.</p>
        </footer>
    </div>
</body>

</html>